These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10829255)

  • 21. Integrating pharmacokinetics, pharmacodynamics and pharmacogenomics to predict outcomes in antibacterial therapy.
    Gumbo T
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):32-42. PubMed ID: 18175265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacology of antimicrobial drugs for the treatment of septic neonatal calves.
    Wilcke JR
    Vet Clin North Am Food Anim Pract; 1991 Nov; 7(3):695-711. PubMed ID: 1760757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic therapy for severe bacterial infections: correlation between the inhibitory quotient and outcome.
    Spanu T; Santangelo R; Andreotti F; Cascio GL; Velardi G; Fadda G
    Int J Antimicrob Agents; 2004 Feb; 23(2):120-8. PubMed ID: 15013036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What's new in the antibiotic pipeline.
    Lee VJ; Miller GH; Yagisawa M
    Curr Opin Microbiol; 1999 Oct; 2(5):475-82. PubMed ID: 10508732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance: action by laboratories today for a cure tomorrow.
    Kanungo R
    Indian J Med Microbiol; 2011; 29(3):205-6. PubMed ID: 21860096
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiresistance and 'superbugs'.
    Livermore D
    Commun Dis Public Health; 1998 Jun; 1(2):74-6. PubMed ID: 9644116
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibacterial antibiotics. Classification, principles and utilization rules].
    Bergogne-Bérézin E
    Rev Prat; 1998 May; 48(9):991-7. PubMed ID: 11767360
    [No Abstract]   [Full Text] [Related]  

  • 28. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamics, a tool for a better use of antibiotics?
    Crokaert F
    Intensive Care Med; 2001 Feb; 27(2):340-3. PubMed ID: 11396276
    [No Abstract]   [Full Text] [Related]  

  • 30. Doripenem: an early look at a carbapenem not yet approved for pediatrics.
    Overturf GD
    Pediatr Infect Dis J; 2010 Feb; 29(2):163-5. PubMed ID: 20135831
    [No Abstract]   [Full Text] [Related]  

  • 31. Update on Susceptibility Testing: Genotypic and Phenotypic Methods.
    Humphries RM
    Clin Lab Med; 2020 Dec; 40(4):433-446. PubMed ID: 33121613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [STRATEGY OF ANTIBACTERIAL THERAPY OF SEPSIS. PART I].
    Shapoval SD; Savon IL; Martyniuk VB; Vasylevska LA; Yakunych AM; Maksimova OO; Sofilkanych MM
    Klin Khir; 2015 Jun; (6):62-6. PubMed ID: 26521472
    [No Abstract]   [Full Text] [Related]  

  • 33. Towards a rational antimicrobial testing policy in the laboratory.
    Banaji N; Oommen S
    Indian J Med Microbiol; 2011; 29(3):209-12. PubMed ID: 21860098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methodology of prevention of antibiotic resistance.
    Shetty A
    J Assoc Physicians India; 2010 Dec; 58 Suppl():47-8. PubMed ID: 21568010
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
    Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
    Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
    [No Abstract]   [Full Text] [Related]  

  • 36. Ceftazidime: summary of the first international symposium.
    Young LS
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():349-52. PubMed ID: 19803013
    [No Abstract]   [Full Text] [Related]  

  • 37. [Not Available].
    Müller A
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S6-S7. PubMed ID: 30453362
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibacterial agents in pediatrics.
    San Joaquin VH; Stull TL
    Infect Dis Clin North Am; 2000 Jun; 14(2):341-55, viii. PubMed ID: 10829259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial activity and pharmacokinetics/pharmacodynamics of the novel glycylcycline, tigecycline.
    Peterson LR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):163-4. PubMed ID: 16105559
    [No Abstract]   [Full Text] [Related]  

  • 40. Is there a need for the antibiotic susceptibility testing of anaerobic bacteria?
    Nagy E; Schuetz A
    Anaerobe; 2015 Feb; 31():2-3. PubMed ID: 25464139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.